FMP
First Trust Nasdaq Pharmaceuticals ETF
FTXH
NASDAQ
The fund will normally invest at least 90% of its net assets (including investment borrowings) in the common stocks and depository receipts that comprise the index. The index is designed to provide exposure to U.S. companies comprising the pharmaceutical sector that have been selected based upon their liquidity and weighted based upon their cumulative score on three investing factors: volatility, value and growth. It is non-diversified.
26.98 USD
0.235 (0.871%)
Historical Prices
From:
To:
We are unable to load the chart at this time.
About
ceo
N/A
sector
Financial Services
industry
Asset Management
website
N/A
exchange
NASDAQ
Description
The fund will normally invest at least 90% of its net assets (including investment borrowings) in the common stocks and depository receipts that comprise the index. The index is designed to provide exposure to U.S. companies comprising the pharmaceutical sector that have been selected based upon their liquidity and weighted based upon their cumulative score on three investing factors: volatility, value and growth. It is non-diversified.
CIK
0001552740
ISIN
US33738R8372
CUSIP
33738R837
Address
N/A
Phone
NA
Country
US
Employee
N/A
IPO Date
Sep 22, 2016
Sector Weightings
We are unable to load the chart at this time.
Country Weightings
We are unable to load the chart at this time.
Financial Statement
We are unable to load the chart at this time.
Earnings
We are unable to load the chart at this time.
FTXH Financial Summary
ISIN
US33738R8372
Exchange
NASDAQ
Beta
0.58
Market Cap
15.76M
52-Week
25.73-29.72
Volume Avg.
2.97k
Price
26.98
Country
US
Management Assets
-
Total Holdings
-
NAV
-
NAV Currency
-
Upgrades and Downgrades
We are unable to load this data!
Financial Information
Financial Summary Real-Time Price
Financial Statements
Financial Quarter Statements
Ratios Analysis
Dupont Analysis
Free Cashflow
Operating Data
Balance Sheet Data
Financial Modelling
Discounted Cashflow Model
Discounted Cashflow Model Levered
Free Cashflow Build-Up
Terminal Value
Intrinsic Value
Weighted Average Cost of Capital
Market Information
Stock Value
Latest FTXH News
It looks like there's no news available.
